Health ❯ Nutrition ❯ Weight Management ❯ Obesity

Weight Loss Medications

AstraZeneca’s Oral GLP‑1 Elecoglipron Delivers Strong Phase 2 Weight and Blood‑Sugar Results

The company has launched a Phase 3 program to evaluate long‑term safety, refine dosing and run dedicated cardiovascular and kidney outcome trials.

Oprah Winfrey Recasts Obesity as Disease in New Book, Backs GLP-1s as Long-Term Care